Contraception - sterilization
Exam Tips
- Vasectomy is not immediately effective: test the semen at about 12 weeks and continue contraception until clearance.
- For OSCE counselling, always state permanence, regret risk, lack of STI protection, and that reversal is not routinely offered on the NHS.
- Quote failure rates: vasectomy around 0.05% lifetime after negative PVSA; laparoscopic tubal occlusion around 0.5% lifetime.
- If pregnancy occurs after female sterilization, think ectopic first and investigate urgently.
- Post-vasectomy red flags: rapidly enlarging unilateral haematoma, persistent bleeding, infection, or severe persistent pain.
Definition
Sterilization is a highly effective contraceptive strategy intended to be permanent, achieved in men by vasectomy (interruption of the vas deferens) and in women by tubal occlusion/interruption of the fallopian tubes. It prevents sperm and ovum from meeting, but does not protect against sexually transmitted infections, and patients must be counselled that reversal is technically possible but not routinely available on the NHS.
Pathophysiology
In vasectomy, each vas deferens is occluded and divided (commonly via minimally invasive/no-scalpel access), so sperm produced in the testes cannot enter the ejaculate; sperm are instead broken down and reabsorbed in the epididymal tract. Sterility is not immediate because residual sperm remain distal to the occlusion, which is why post-vasectomy semen analysis (PVSA) is required before stopping other contraception. In female sterilization, mechanical occlusion (clips/rings) or tissue destruction of fallopian tubes blocks gamete transport and fertilization; if failure occurs, altered tubal transport contributes to a higher relative risk of ectopic implantation. See Figure: male reproductive tract (testis-epididymis-vas deferens) and Figure: fallopian tube anatomy/occlusion sites.
Risk Factors
- Younger age at sterilization and later life change in circumstances (higher regret risk)
- Uncertain or fluctuating desire for future fertility
- Inadequate understanding that sterilization is intended to be permanent
- Failure to use interim contraception before confirmed vasectomy clearance
- Previous scrotal surgery/anatomical difficulty (technical complexity for vasectomy)
- Comorbidity increasing anaesthetic/surgical risk (particularly for laparoscopic female sterilization)
Clinical Features
Symptoms
- Usually none at presentation apart from request for permanent contraception
- Post-vasectomy mild scrotal pain/discomfort and bruising for a few days
- Complication symptoms: persistent pain, fever, wound discharge, enlarging unilateral scrotal swelling/haematoma
- Late failure may present as partner pregnancy
Signs
- Local post-procedure tenderness/ecchymosis at scrotal puncture or incision site
- Scrotal haematoma or signs of wound infection (erythema, warmth, discharge) if complicated
- In chronic post-vasectomy pain syndrome, focal epididymal/testicular tenderness may be present
- No systemic examination findings are expected in uncomplicated elective care
Investigations
Management
Lifestyle Modifications
- Provide shared decision-making counselling with written information, including alternatives (LARC) and permanence/regret risk
- Use effective contraception until vasectomy success is confirmed by PVSA
- After vasectomy: rest, avoid strenuous activity until comfortable, abstain from sex for 2-7 days, and wear supportive underwear (including overnight for first 48 hours)
- Advise urgent review for persistent bleeding, increasing unilateral scrotal swelling, severe pain, or infection symptoms
- Reinforce that sterilization does not prevent STIs; advise condom use when STI risk exists
Pharmacological Treatment
Non-opioid analgesia after vasectomy
- Paracetamol 1 g orally every 4-6 hours when required (max 4 g/day)
- Ibuprofen 400 mg orally up to three times daily with food when required (max 1.2 g/day OTC; higher only on prescription)
Use NSAIDs only if appropriate: avoid in active peptic ulcer disease, severe renal impairment, NSAID hypersensitivity/asthma exacerbated by NSAIDs, and caution with anticoagulants/CVD risk. If NSAIDs contraindicated, paracetamol-first strategy is reasonable.
Surgical / Interventional
- Male sterilization (vasectomy): minimally invasive/no-scalpel or scalpel approach with vas occlusion (cautery, ligation/clips, or intravas methods)
- Female sterilization: laparoscopic tubal occlusion (commonly clips such as Filshie clips in UK practice) or tubal destruction/interruption; mini-laparotomy if laparoscopy unsuitable
- Counsel that reversal is not routinely NHS-funded and success declines with time from vasectomy
- Safety warnings: female laparoscopic sterilization carries anaesthetic and visceral/vascular injury risk; failed female sterilization pregnancies are more likely to be ectopic than in general conceptions
Complications
- Procedure failure (vasectomy lifetime failure about 1 in 2000 after negative semen testing; laparoscopic tubal occlusion lifetime failure about 1 in 200)
- Need for continued contraception until confirmed vasectomy clearance
- Scrotal haematoma and wound infection after vasectomy
- Chronic post-vasectomy pain syndrome (persistent pain >3 months; uncommon severe persistent cases)
- Ectopic pregnancy if female sterilization fails
- Rare severe laparoscopic complications in female sterilization (bowel/bladder/vascular injury, conversion to laparotomy, very rare death)
Prognosis
Overall prognosis is excellent for contraception efficacy when counselling, technique, and follow-up are done correctly. Most men recover quickly from vasectomy with minor short-term discomfort, but a small minority develop chronic pain or late failure. In women, efficacy is high, though failures are uncommon and clinically important because of ectopic risk.
Sources & References
✅NICE Guidelines(1)
- Contraception - sterilization[overview]